Back to search
Stage IB Hepatocellular Carcinoma AJCC v8
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Stage IB Hepatocellular Carcinoma AJCC v8 trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Stage IB Hepatocellular Carcinoma AJCC v8 trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase II trial tests whether regorafenib and durvalumab work to shrink tumors in patients with high-risk liver cancer. Regorafenib may stop the growth of t…
This phase Ib trial investigates the side effects of durvalumab and tremelimumab after radioembolization (radiation particles against liver tumors) and to see h…